Cargando…
Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies
OBJECTIVE: Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer’s disease (AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to what degree the homocysteine (Hcy) levels in blood and cerebrospinal fluid (CSF) were elevated in AD patients compar...
Autores principales: | Zhang, Ling, Xie, Xinhua, Sun, Yangyan, Zhou, Futao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586177/ https://www.ncbi.nlm.nih.gov/pubmed/36276430 http://dx.doi.org/10.2147/NDT.S383654 |
Ejemplares similares
-
Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
por: Zhou, Futao, et al.
Publicado: (2023) -
Homocysteine Level and Risk of Abdominal Aortic Aneurysm: A Meta-Analysis
por: Cao, Hui, et al.
Publicado: (2014) -
The associations between the MAPT polymorphisms and Alzheimer’s disease risk: a meta-analysis
por: Zhou, Futao, et al.
Publicado: (2017) -
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond
por: Dayon, Loïc, et al.
Publicado: (2017) -
Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
por: Nguyen, V. Phu, et al.
Publicado: (2023)